Sammer Marzouk’s research introduces the Dynamic Drug Response Network, which integrates wearable quantum biosensors, edge-based AI analysis, and responsive nanomedicines. By continuously tracking biomarkers and automatically tuning drug release, this framework offers personalized, adaptive therapies for conditions like diabetes and cancer.

Key points

• Miniaturized quantum biosensors monitor dozens of biomarkers at attomolar sensitivity for real-time health profiling.
• Edge computing with federated learning analyzes continuous biodata instantaneously to predict optimal dosing.
• Shape-shifting nanoparticles and engineered cellular circuits adjust drug release in a closed-loop control system.

Why it matters: This dynamic, feedback-driven system represents a paradigm shift toward fully personalized, continuously adaptive therapies, promising enhanced efficacy and reduced side effects across complex diseases.